Found: 10
Select item for more details and to access through your institution.
When can real‐world data generate real‐world evidence?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 1, p. 1, doi. 10.1002/pds.5715
- By:
- Publication type:
- Article
Categorization of COVID‐19 severity to determine mortality risk.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 721, doi. 10.1002/pds.5436
- By:
- Publication type:
- Article
Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 9, p. 973, doi. 10.1002/pds.4065
- By:
- Publication type:
- Article
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 11, p. 1223, doi. 10.1002/pds.3712
- By:
- Publication type:
- Article
Drug risk assessment and data reuse.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 1, p. 107, doi. 10.1002/pds.3518
- By:
- Publication type:
- Article
Review of Oncology and Hematology Drug Product Approvals at the US Food and Drug Administration Between July 2005 and December 2007.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 4, p. 230, doi. 10.1093/jnci/djp515
- By:
- Publication type:
- Article
A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad339
- By:
- Publication type:
- Article
Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United States.
- Published in:
- PLoS ONE, 2023, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0281365
- By:
- Publication type:
- Article
Describing characteristics and treatment patterns of patients hospitalized with COVID-19 by race and ethnicity in a national RWD during the early months of the pandemic.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0267815
- By:
- Publication type:
- Article
Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues.
- Published in:
- Statistical Methods in Medical Research, 2008, v. 17, n. 5, p. 515, doi. 10.1177/0962280207081862
- By:
- Publication type:
- Article